Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics (NASDAQ:HZNP) Rating Reiterated by Stifel Nicolaus
05:10am, Sunday, 12'th Apr 2020
Stifel Nicolaus reaffirmed their buy rating on shares of Horizon Therapeutics (NASDAQ:HZNP) in a research note issued to investors on Wednesday morning, TipRanks reports. They currently have a $45.00
Is Horizon Therapeutics (NASDAQ:HZNP) Using Too Much Debt?
01:23pm, Saturday, 11'th Apr 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
$0.22 EPS Expected for Horizon Therapeutics PLC (NASDAQ:HZNP) This Quarter
10:08am, Saturday, 11'th Apr 2020
Analysts expect Horizon Therapeutics PLC (NASDAQ:HZNP) to report $0.22 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates
Ladenburg Thalmann Financial Services Inc. Buys 6,152 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP)
11:00am, Friday, 10'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lifted its stake in Horizon Therapeutics PLC (NASDAQ:HZNP) by 64.2% during the fourth quarter, according to the company in its most recent 13F filing with th
Brian K. Beeler Sells 2,370 Shares of Horizon Therapeutics PLC (NASDAQ:HZNP) Stock
09:04am, Friday, 10'th Apr 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Brian K. Beeler sold 2,370 shares of the firm’s stock in a transaction on Monday, April 6th. The shares were sold at an average price of $32.50, for a tota
Horizon Therapeutics plc Named One of the 2020 Best Workplaces in Health Care and Biopharma by Fortune and Great Place to Work
01:00pm, Thursday, 09'th Apr 2020
Horizon Therapeutics plc (NASDAQ:HZNP) today announced it has been selected as one of the 2020 Best Workplaces in Health Care and Biopharma by Fortune and Great Place to Work®.
Guggenheim Capital LLC Makes New $306,000 Investment in Horizon Therapeutics PLC (NASDAQ:HZNP)
10:12am, Thursday, 09'th Apr 2020
Guggenheim Capital LLC bought a new position in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Ex
Analyzing Horizon Therapeutics (NASDAQ:HZNP) and Morphic (NASDAQ:MORF)
07:32am, Wednesday, 08'th Apr 2020
Horizon Therapeutics (NASDAQ:HZNP) and Morphic (NASDAQ:MORF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings
Norges Bank Invests $75.96 Million in Horizon Therapeutics PLC (NASDAQ:HZNP)
10:44am, Tuesday, 07'th Apr 2020
Norges Bank bought a new position in Horizon Therapeutics PLC (NASDAQ:HZNP) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bou
Horizon Therapeutics (NASDAQ:HZNP) Stock Rating Upgraded by BidaskClub
08:12am, Saturday, 04'th Apr 2020
Horizon Therapeutics (NASDAQ:HZNP) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Saturday, BidAskClub reports. Oth
Should You Buy These 3 Biotechs Now?
10:45am, Friday, 03'rd Apr 2020
These drug developers just released new clinical trial results.
Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Sells $59,347.08 in Stock
09:12am, Friday, 03'rd Apr 2020
Horizon Therapeutics PLC (NASDAQ:HZNP) EVP Barry Moze sold 2,106 shares of Horizon Therapeutics stock in a transaction on Monday, March 30th. The shares were sold at an average price of $28.18, for a
Horizon acquires Curzion Pharma for $45M
01:49pm, Thursday, 02'nd Apr 2020
Horizon Therapeutics (HZNP -0.6%) has acquired San Diego, CA-based Curzion Pharmaceuticals, the developer of an oral selective lysophosphatidic acid 1 receptor (LPAR1) antagonist called CZN001 (rename
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral selecti
